Nawar Hanna

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study

Nawar Hanna, Maxine Sun, Christian P. Meyer et al. · Journal of Clinical Oncology · 2016 · 228 citations · Full text

A Non–Cancer-Related Survival Benefit Is Associated With Partial Nephrectomy

Maxine Sun, Quoc‐Dien Trinh, Marco Bianchi et al. · European Urology · 2011 · 131 citations

Urology, Surgical Oncology, Genitourinary Cancer +4

Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma

Thomas Seisen, Ross Krasnow, Joaquim Bellmunt et al. · Journal of Clinical Oncology · 2017 · 124 citations

Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series

Nawar Hanna, Maxine Sun, Quoc‐Dien Trinh et al. · European Urology · 2011 · 87 citations

Laparoscopy, Urology, Surgical Oncology +12